← Leaderboards
Sanjeev Chawla
University Of Pennsylvania
$773,608
Attributed
$1,547,216
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $398.6K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,547,216 · 1
By mechanism
R01$1,547,216 · 1
Top collaborators
- Suyash Mohan4 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Robert H Vonderheide$28,425,019
- Robert I. Grossman$14,356,756
- Christos Davatzikos$42,474,609
- Felix W Wehrli$41,563,685
- Helena Chang Chui$16,982,623
Others in their field
Other Emerging Leaders on “Fda Approved”
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Xinhua Li · Nano Terra, Inc.$32,520,955
- Klaus Romero · Critical Path Institute$31,739,260
- James Dale Berry · Brigham And Women'S Hospital$26,348,733
- Andrew S Huhn · Johns Hopkins University$17,756,243
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
Research focus
Fda ApprovedFollow-UpAntimitotic AgentsEnsureBrain RegionAdverse EffectsBedsCell ProliferationBrainChemotherapeutic AgentCholineClinical EfficacyClinical PracticeCancer CellCell KillingComputer ModelsContrast EnhancedDesignChemoradiationDiffusionDoseDosimetryElectric FieldGlioblastoma
Grant awards (4)
Whole-brain Spectroscopy Guided Personalized Mapping of Transducer Arrays for Glioblastoma Patients Receiving Tumor Treating Fields$392,603
R01 · FY2025 · CA
Whole-brain Spectroscopy Guided Personalized Mapping of Transducer Arrays for Glioblastoma Patients Receiving Tumor Treating Fields$372,319
R01 · FY2024 · CA
Whole-brain Spectroscopy Guided Personalized Mapping of Transducer Arrays for Glioblastoma Patients Receiving Tumor Treating Fields$383,706
R01 · FY2022 · CA
Whole-brain Spectroscopy Guided Personalized Mapping of Transducer Arrays for Glioblastoma Patients Receiving Tumor Treating Fields$398,588
R01 · FY2021 · CA